- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Illnesses, Multiple
Total 42076 results
-
University Hospital, MontpellierCompletedProgressive Multiple Sclerosis | Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | ControlsFrance
-
University of South FloridaGenentech, Inc.Active, not recruitingPathologic Processes | Nervous System Diseases | Immune System Diseases | Multiple Sclerosis | Demyelinating Diseases | Autoimmune Diseases | Relapsing Remitting Multiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
Johns Hopkins UniversityCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Biogen; Copenhagen University Hospital, Hvidovre; Signifikans...CompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
University of WashingtonNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingCommunication | Chronic Illness | Discrimination, Racial | Bias, RacialUnited States
-
Dimitrios KarussisCompletedMultiple Sclerosis (MS)Israel
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedMultiple Sclerosis, ProgressiveUnited Kingdom
-
Virginia Commonwealth UniversityAgency for Healthcare Research and Quality (AHRQ)RecruitingMental Health | Health Behavior | Multiple Chronic Conditions | Social Determinants of HealthUnited States
-
Johns Hopkins UniversityUnited States Department of DefenseCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Johns Hopkins UniversityCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
University of LouisvilleBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Relapsing-remittingUnited States
-
Tiziana Life Sciences LTDRecruitingSecondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Japan, Bulgaria, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, Slo... and more
-
Assistance Publique - Hôpitaux de ParisCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveFrance
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedSecondary Progressive Multiple SclerosisUnited States
-
University of California, Los AngelesRecruitingPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University College DublinCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisIreland
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
Imperial College LondonGlaxoSmithKline; University College, London; Medical Research Council; Queen Mary... and other collaboratorsCompletedRelapsing-remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Institut National de la Santé Et de la Recherche...Not yet recruitingIdiopathic Environmental IntoleranceFrance
-
Shahid Beheshti UniversityCompletedInflammation | Critical Illness | Enteral Nutrition | Multiple Organ Failure | Infection ComplicationIran, Islamic Republic of
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Brainstorm-Cell TherapeuticsCompletedMultiple Sclerosis, Chronic ProgressiveUnited States
-
University Hospital, MontpellierGenzyme, a Sanofi CompanyTerminatedProgressive Multiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingFrance
-
BayerCompletedSecondary Progressive Multiple Sclerosis (SPMS) | Relapsing Remitting Multiple Sclerosis (RRMS)Portugal
-
Sohag UniversityNot yet recruitingRespiratory IllnessesEgypt
-
University of CincinnatiNational Institute of Nursing Research (NINR)CompletedPatient Engagement | Parent-Child Relations | Parenting | Self Efficacy | Patient Empowerment | Premature Infant Disease | Family Research | Chronic Conditions, MultipleUnited States
-
IRCCS San RaffaeleAzienda Socio Sanitaria Territoriale della Valle OlonaRecruitingMultiple SclerosisItaly
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
University of FloridaPatient-Centered Outcomes Research InstituteCompletedED Patients With Chronic Medical IllnessesUnited States
-
Ersta Sköndal University CollegeRecruitingEnd of Life | Chronic Illness | Cancer Metastatic | FamilySweden
-
Seton Healthcare FamilyUniversity of Texas at AustinCompletedQuality of Life | Chronic Disease | Chronic IllnessUnited States
-
Opexa Therapeutics, Inc.CompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Innobioscience SpAPontificia Universidad Catolica de Chile; University of Chile; Universidad Austral...UnknownMultiple Sclerosis, Secondary Progressive | Primary Progressive Multiple SclerosisChile
-
Sheba Medical CenterUnknownMultiple Sclerosis, Chronic Progressive | Relapsing Remitting Multiple SclerosisIsrael
-
Mahidol UniversityCompletedSepsis | Critical Illness | Septic Shock | Morality | Pharmacokinetic | Carbapenem | Pharmacodynamic | Clinical Outcome | Organ Failure, MultipleThailand
-
Tiziana Life Sciences LTDWithdrawnMultiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis
-
Friedemann PaulRoche Pharma AGActive, not recruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveGermany
-
MediciNovaNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaboratorsCompletedSafety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingChronic Medical ConditionUnited States
-
Johns Hopkins UniversityNational Institute of Nursing Research (NINR)Completed
-
University Hospitals Cleveland Medical CenterThe Cleveland Clinic; Case Western Reserve UniversityCompletedGastrostomy | Chronic Illness | Caregiver | Mindfulness | Mechanical Ventilation Pressure HighUnited States
-
C. T. Lamont Primary Care Research CentreCompletedQuality of Life | Chronic IllnessCanada
-
Oregon Health and Science UniversityUniversity of Missouri-Columbia; Vanderbilt University Medical CenterRecruitingHypertension | Multiple Chronic ConditionsUnited States
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisGermany
-
Instituto Universitario de Oftalmobiología Aplicada...Hospital del Río Hortega; Fundación Eugenio Rodríguez PascualEnrolling by invitationProgressive Multiple Sclerosis | Multiple Sclerosis | Clinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisSpain
-
Regeneron PharmaceuticalsCompletedHealthy | Chronic Stable IllnessUnited States
-
University of ManchesterNIHR CLAHRCCompletedDepression | Multiple Chronic ConditionsUnited Kingdom
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)Not yet recruitingObesity | Multiple Chronic ConditionsUnited States
-
Rennes University HospitalRecruitingMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveFrance